Drugs / Δ9-Tetrahydrocannabivarin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07636356 | Jul 2026 → May 2028 expected | nicotine dependence | University of California, Los Angeles | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Δ9-tetrahydrocannabivarin | “This study will randomize 32 non-treatment-seeking individuals who smoke cigarettes daily into a randomized, crossover, double-blind, placebo-controlled study testing the...” NCT07636356 ↗ |
| Known as | Δ9-THCV | “This study will randomize 32 non-treatment-seeking individuals who smoke cigarettes daily into a randomized, crossover, double-blind, placebo-controlled study testing the...” NCT07636356 ↗ |
| Route | Oral | “10mg Δ9-Tetrahydrocannabivarin oral gummy” NCT07636356 ↗ |